医学
脂蛋白(a)
动脉粥样硬化性心血管疾病
风险因素
疾病
内科学
脂蛋白
重症监护医学
心脏病学
生物信息学
胆固醇
生物
作者
Harpreet Bhatia,Michael J. Wilkinson
摘要
Lipoprotein(a) (Lp(a)) is an established risk factor for multiple cardiovascular diseases. Several lines of evidence including mechanistic, epidemiologic, and genetic studies support the role of Lp(a) as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis/calcific aortic valve disease (AS/CAVD). Limited therapies currently exist for the management of risk associated with elevated Lp(a), but several targeted therapies are currently in various stages of clinical development. In this review, we detail evidence supporting Lp(a) as a causal risk factor for ASCVD and AS/CAVD, and discuss approaches to managing Lp(a)-associated risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI